Robinson, G. W., Korbel, J. O., Jones, D. T. W., Lichter, P., Kool, M., & Pfister, S. (2018). Risk-adapted therapy for young children with medulloblastoma (SJYC07): Therapeutic and molecular outcomes from a multicentre, phase 2 trial. The lancet. Oncology, 19(6), . https://doi.org/10.1016/S1470-2045(18)30204-3
Chicago-Zitierstil (17. Ausg.)Robinson, Giles W., Jan Oliver Korbel, David T. W. Jones, Peter Lichter, Marcel Kool, und Stefan Pfister. "Risk-adapted Therapy for Young Children with Medulloblastoma (SJYC07): Therapeutic and Molecular Outcomes from a Multicentre, Phase 2 Trial." The Lancet. Oncology 19, no. 6 (2018). https://doi.org/10.1016/S1470-2045(18)30204-3.
MLA-Zitierstil (9. Ausg.)Robinson, Giles W., et al. "Risk-adapted Therapy for Young Children with Medulloblastoma (SJYC07): Therapeutic and Molecular Outcomes from a Multicentre, Phase 2 Trial." The Lancet. Oncology, vol. 19, no. 6, 2018, https://doi.org/10.1016/S1470-2045(18)30204-3.